Clinical Study
Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus
Table 4
Multivariate logistic regression analysis.
| | Odds ratio | 95% CI | P value |
| Model 1 | | | | Male/female | 1.80 | 0.55 to 5.84 | 0.32 | Age (years) | 1.48 | 1.21 to 2.12 | <0.0001 | Diabetes duration (years) | 1.74 | 1.46 to 2.07 | <0.0001 | Model 2 | | | | Cholesterol (mg%) | 1.009 | 1.0007 to 1.0182 | 0.03 | Triglycerides (mg%) | 0.99 | 0.9963 to 1.0022 | 0.61 | HbA1c | 1.88 | 1.3101 to 2.7202 | 0.0007 | FPG (mg%) | 0.99 | 0.9899 to 1.0041 | 0.40 | Model 3 | | | | Retinopathy (yes versus no) | 4.14 | 0.3942 to 43.6795 | 0.23 | Peripheral neuropathy (yes versus no) | 15.47 | 5.1626 to 46.3864 | <0.0001 | IMT | 17.84 | 0.3795 to 838.9339 | 0.14 | QTC | 1.03 | 1.0074 to 1.0581 | 0.01 | ABI | 0.29 | 0.0052 to 16.2428 | 0.54 | Model 4 | | | | Smoking (yes versus no) | 2.21 | 1.0859 to 4.5307 | 0.02 | Body mass index (kg/m2) | 1.12 | 1.0530 to 1.2100 | 0.0006 | HT | 1.43 | 0.6713 to 3.0747 | 0.35 |
|
|
HbA1c: glycosylated hemoglobin, FPG: fasting plasma glucose, IMT: intima-media thickness, QTC: corrected QT interval, ABI: ankle-brachial index, and HT: hypertension.
|